His INR (1.7) has yet to become therapeutic (2.5-3.5).
No pronator drift  Sensation: Intact to light touch  On Discharge: AOx3, bilateral surgical pupils, full strength and power throughout upper and lower extremities.
Pertinent Results: [**2150-2-25**] 08:30AM BLOOD WBC-14.2* RBC-3.70* Hgb-11.8*# Hct-32.7*# MCV-88 MCH-31.9 MCHC-36.1* RDW-13.8 Plt Ct-217 [**2150-2-25**] 11:47AM BLOOD WBC-12.7* RBC-3.27* Hgb-10.5* Hct-28.5* MCV-87 MCH-32.2* MCHC-36.9* RDW-14.5 Plt Ct-229 [**2150-2-26**] 01:43AM BLOOD WBC-21.2*# RBC-3.16* Hgb-10.1* Hct-28.0* MCV-89 MCH-32.0 MCHC-36.1* RDW-14.4 Plt Ct-248 [**2150-2-27**] 05:33AM BLOOD WBC-16.9* RBC-2.79* Hgb-8.7* Hct-24.8* MCV-89 MCH-31.3 MCHC-35.1* RDW-14.5 Plt Ct-183 [**2150-2-28**] 07:30PM BLOOD WBC-11.5* RBC-2.78* Hgb-9.0* Hct-25.2* MCV-91 MCH-32.2* MCHC-35.5* RDW-14.5 Plt Ct-252 [**2150-3-1**] 06:50AM BLOOD WBC-12.0* RBC-2.84* Hgb-9.2* Hct-25.6* MCV-90 MCH-32.4* MCHC-35.8* RDW-14.5 Plt Ct-263 [**2150-3-2**] 05:45AM BLOOD WBC-13.2* RBC-2.95* Hgb-9.4* Hct-26.4* MCV-89 MCH-31.9 MCHC-35.7* RDW-14.5 Plt Ct-307 [**2150-3-3**] 05:33AM BLOOD WBC-10.9 RBC-3.15* Hgb-9.9* Hct-28.0* MCV-89 MCH-31.4 MCHC-35.3* RDW-14.8 Plt Ct-328 [**2150-3-5**] 05:40AM BLOOD WBC-12.4* RBC-3.04* Hgb-9.7* Hct-27.5* MCV-91 MCH-31.9 MCHC-35.2* RDW-14.7 Plt Ct-382 [**2150-3-7**] 07:45AM BLOOD WBC-11.6* RBC-3.21* Hgb-9.7* Hct-29.3* MCV-91 MCH-30.3 MCHC-33.3 RDW-14.6 Plt Ct-426 [**2150-3-8**] 07:56AM BLOOD WBC-12.5* RBC-3.33* Hgb-10.4* Hct-30.2* MCV-91 MCH-31.2 MCHC-34.4 RDW-14.4 Plt Ct-473* [**2150-3-10**] 05:55AM BLOOD WBC-10.9 RBC-3.22* Hgb-9.9* Hct-29.0* MCV-90 MCH-30.9 MCHC-34.2 RDW-14.4 Plt Ct-461* [**2150-3-12**] 07:50AM BLOOD WBC-9.9 RBC-3.42* Hgb-10.7* Hct-31.0* MCV-91 MCH-31.4 MCHC-34.6 RDW-14.2 Plt Ct-505* [**2150-3-13**] 09:05AM BLOOD WBC-9.2 RBC-3.55* Hgb-10.8* Hct-32.0* MCV-90 MCH-30.4 MCHC-33.7 RDW-14.2 Plt Ct-508* [**2150-3-14**] 08:00AM BLOOD WBC-9.8 RBC-3.59* Hgb-10.7* Hct-32.6* MCV-91 MCH-29.8 MCHC-32.9 RDW-14.3 Plt Ct-494* [**2150-2-25**] 06:42AM BLOOD PT-23.8* PTT-30.2 INR(PT)-2.3* [**2150-2-25**] 08:30AM BLOOD PT-21.1* PTT-28.1 INR(PT)-2.0* [**2150-2-25**] 11:47AM BLOOD PT-18.6* PTT-24.1 INR(PT)-1.7* [**2150-2-26**] 01:43AM BLOOD PT-14.2* PTT-21.2* INR(PT)-1.2* [**2150-3-5**] 05:40AM BLOOD PT-13.3 PTT-38.4* INR(PT)-1.1 [**2150-3-5**] 07:35PM BLOOD PT-14.6* PTT-60.6* INR(PT)-1.3* [**2150-3-8**] 10:10PM BLOOD PT-15.9* PTT-96.4* INR(PT)-1.4* [**2150-3-10**] 03:15PM BLOOD PT-16.7* PTT-56.2* INR(PT)-1.5* [**2150-3-11**] 09:13PM BLOOD PT-19.0* PTT-72.0* INR(PT)-1.8* [**2150-3-12**] 07:50AM BLOOD PT-21.4* PTT-95.8* INR(PT)-2.0* [**2150-3-13**] 12:55AM BLOOD PT-22.9* PTT-120.6* INR(PT)-2.2* [**2150-3-13**] 09:05AM BLOOD PT-23.3* PTT-75.0* INR(PT)-2.3* [**2150-3-13**] 04:56PM BLOOD PT-22.0* PTT-53.2* INR(PT)-2.1* [**2150-3-14**] 02:43AM BLOOD PT-22.9* PTT-69.7* INR(PT)-2.2* [**2150-3-14**] 08:00AM BLOOD PT-24.9* PTT-97.4* INR(PT)-2.4* [**2150-3-14**] 10:00AM BLOOD PT-25.1* PTT-92.9* INR(PT)-2.5*  [**2150-2-25**] 08:30AM BLOOD Glucose-170* UreaN-14 Creat-0.8 Na-138 K-4.8 Cl-103 HCO3-27 AnGap-13 [**2150-2-25**] 11:47AM BLOOD Glucose-195* UreaN-14 Creat-0.8 Na-138 K-5.2* Cl-105 HCO3-27 AnGap-11 [**2150-3-12**] 07:50AM BLOOD Calcium-9.1 Phos-3.9 Mg-2.3 Iron-38*  IMAGING: Head CT [**2-25**]: IMPRESSION: 1.
Head CT [**2150-2-25**] (post-evacuation): IMPRESSION: 1.
Head CT [**2150-3-4**] IMPRESSION: Status post evacuation of subdural hematoma layering over the left cerebral convexity, without evidence of new intracranial hemorrhage, mass effect or herniation.
The CSF-atttenuation fluid, occupying the more anterior portion of the left frontal extra- axial space, was present on the initial scan of [**2150-2-25**], and may reflect decompression and re-expansion of pre-existent compartmentalized subdural space, or true hygroma.
Head CT [**2150-3-13**] FINDINGS: The patient is status post left frontoparietal craniotomy with expected amount of pneumocephalus, which has decreased compared to the prior study.
Neurological exam remained normal.
Blood pressure was closely monitored.
Therapeutic INR was achieved without any evidence of progression of SDH by CT.
He will have his INR checked 5 days after discharge.
#Mechanical mitral valve - TTE on [**3-2**] showed a well-seated prosthesis with normal disc motion and transvalvular gradients, without MR. Heparin bridge to therapeutic anticoagulation with warfarin was achieved, as above, with a goal INR 2.5-3.5.
#Iron-deficiency anemia - Hematocrit remained stable, obviating the need for blood transfusion.
Medications on Admission: ASA 81 mg Albuterol INR Advair 500/50 [**Hospital1 **] Symbicort 160/4.5 [**Hospital1 **] Lasix 40 mg daily Singulair 10 mg daily Simvastatin 20 mg daily Spiriva 18 mcg daily Warfarin 15 mg daily Ranitidine 150 mg [**Hospital1 **] Colace 100 mg [**Hospital1 **] Ambien 10 mg QHS/PRN insomnia Colchicine daily/PRN gout flare   Discharge Medications: 1.
Surgery to remove the blood was performed on [**2150-2-25**] without complications.
?Inform the person who books your appointment that you will need a CT scan of the brain without contrast prior to the appointment.
Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 9001**], MD Phone:[**Telephone/Fax (1) 250**] Date/Time:[**2150-5-15**] 2:40 Provider: [**Name10 (NameIs) 1571**] FUNCTION LAB Phone:[**Telephone/Fax (1) 609**] Date/Time:[**2150-5-29**] 9:40 Provider: [**First Name11 (Name Pattern1) 1569**] [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **], M.D.
Phone:[**Telephone/Fax (1) 612**] Date/Time:[**2150-5-29**] 10:00    Completed by:[**2150-3-15**
